News

ARCHIVE

Day: June 11, 2019

Panag Pharma Completes Phase 3 Trial WITH AWAYE™

Panag Pharma Inc., a subsidiary of Tetra Bio-Pharma Inc., today announced completion of Panag 001, its Phase 3 clinical trial evaluating the safety and efficacy of Topical-A, now branded as Awaye™ for the treatment of pain caused by osteoarthritis of the knee.

Read More »
Close Menu

STAY UPDATED.
GET THE LASTEST NEWS.